Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review
- PMID: 33272372
- DOI: 10.1016/j.jacc.2020.10.009
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review
Abstract
Over 1.5 million deaths worldwide are caused by neurocardiogenic syndromes. Furthermore, the consequences of deleterious brain-heart interactions are not limited to fatal complications. Cardiac arrhythmias, heart failure, and nonfatal coronary syndromes are also common. The brain-heart axis is implicated in post-stroke cardiovascular complications known as the stroke-heart syndrome, sudden cardiac death, and Takotsubo syndrome, among other neurocardiogenic syndromes. Multiple pathophysiological mechanisms with the potential to be targeted with novel therapies have been identified in the last decade. In the present state-of-the-art review, we describe recent advances in the understanding of anatomical and functional aspects of the brain-heart axis, cardiovascular complications after stroke, and a comprehensive pathophysiological model of stroke-induced cardiac injury.
Keywords: MACE; cardiovascular; inflammation; neurocardiogenic; stroke.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Author Disclosures Dr. Sposato is supported by the Kathleen & Dr. Henry Barnett Research Chair in Stroke Research (Western University, London, Ontario, Canada), the Edward and Alma Saraydar Neurosciences Fund (London Health Sciences Foundation), and the Opportunities Fund of the Academic Health Sciences Center Alternative Funding Plan of the Academic Medical Organization of Southwestern Ontario; has served as a speaker and received consulting honoraria from Boehringer Ingelheim, Pfizer, Bayer, and Gore; has received research grants from Boehringer Ingelheim and Bayer; and is member of the Editorial Board of Neurology and Stroke Journals and the World Stroke Academy (Webinar platform of the World Stroke Organization). Dr. Murthy is supported by the National Institutes of Health (K23NS105948) and the Leon Levy Foundation. Dr. Bahit has served as a speaker for and received consulting honoraria from Pfizer. Dr. Scheitz has received a research grant from Corona-Stiftung, Germany. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical